Regenerative Medicine Texas: The 6-City Access Guide for 2026 Patients

Picture a Texan in their fifties, waking each morning to the familiar ache of chronic knee pain. Their orthopedic surgeon has recommended total knee replacement surgery. The recovery timeline stretches months into the future, and the risks feel overwhelming. They find themselves wondering: is surgery truly the only option, and where in Texas can they explore alternatives?

This scenario plays out thousands of times each year across the Lone Star State. Osteoarthritis affects over 32.5 million Americans, creating a healthcare burden exceeding $136 billion annually. More than 600,000 knee replacements are performed in the United States each year, yet studies suggest up to 80% of patients told they need total knee replacement may not actually require surgery. For Texas patients seeking alternatives, regenerative medicine offers a growing field of evidence-based options.

This guide serves as a comprehensive navigation resource for patients exploring regenerative medicine in Texas. It covers what regenerative treatments exist, the 2026 FDA regulatory landscape, how to evaluate providers, and where to access care across the state’s six major metropolitan areas. Texas occupies a unique position in this field, home to world-class research institutions, a large and diverse patient population, and an expanding network of clinical providers. Whether located in Houston, Dallas, San Antonio, Austin, Fort Worth, or El Paso, this guide provides the foundation for informed decision-making.

What Is Regenerative Medicine? A Plain-Language Overview for Texas Patients

Regenerative medicine encompasses therapies that harness the body’s own biological mechanisms to repair, replace, or regenerate damaged tissues and organs. Unlike traditional orthopedic care that manages symptoms or removes damaged tissue, regenerative medicine aims to restore biological function at the cellular level.

For Texas clinic-based care, the core categories include:

• Cell-based therapies such as stem cells and bone marrow aspirate concentrate (BMAC)
• Blood-derived therapies including platelet-rich plasma (PRP)
• Extracellular vesicle therapies such as exosomes
• Viscosupplementation using hyaluronic acid
• Peptide therapies for targeted tissue repair

The market context establishes the legitimacy of this field. The global regenerative medicine market was valued at approximately $48 to $58 billion in 2025 and is projected to exceed $360 billion by 2034, with North America commanding 43% of global market share. Stem cell therapy accounts for approximately 43.8% of this market, while orthopedic and musculoskeletal conditions represent approximately 33.4% of total regenerative medicine revenue.

Regenerative medicine is not a single treatment but a spectrum of therapies that can be combined and customized based on patient-specific factors including age, injury type, inflammation levels, and health goals.

The 6 Core Regenerative Treatments Available at Texas Clinics in 2026

Understanding available treatment options empowers patients to ask informed questions during consultations. The following overview serves as an educational treatment menu rather than a recommendation.

Stem Cell Therapy

Mesenchymal stem cells (MSCs) represent the primary cell type used in orthopedic regenerative medicine. These cells can be sourced from adipose tissue, bone marrow, or umbilical cord tissue known as Wharton’s Jelly. MSCs release anti-inflammatory signals and growth factors that may promote tissue repair and modulate immune response.

A 2025 meta-analysis of eight randomized controlled trials involving 502 patients confirmed that stem cell therapy for knee osteoarthritis significantly reduces pain and improves function for at least 12 months. Currently, 224 active global clinical trials are investigating stem cell therapies for osteoarthritis, and a $140 million Phase III trial was announced in January 2026.

Unicorn Bioscience reports that more than 90% of their stem cell patients have not progressed to knee replacement surgery. Conditions addressed include osteoarthritis, meniscus injuries, rotator cuff tears, tendon and ligament injuries, and degenerative disc disease.

PRP (Platelet-Rich Plasma) Therapy

PRP involves concentrating the patient’s own platelets from a blood sample using a centrifuge, then injecting the preparation into the treatment site. Platelets release growth factors including PDGF, TGF-β, and VEGF that stimulate tissue healing and reduce inflammation.

PRP is the most widely studied and broadly accepted regenerative injection therapy with the longest clinical track record. Typical costs range from $500 to $2,000 per session, and most insurance providers classify it as experimental. Conditions addressed include tendon injuries, plantar fasciitis, mild-to-moderate osteoarthritis, rotator cuff injuries, and ligament sprains.

BMAC (Bone Marrow Aspiration Concentrate)

BMAC is a concentrated preparation of bone marrow cells aspirated from the patient’s iliac crest. This preparation includes stem cells, platelets, and growth factors, combining regenerative properties in a potent autologous option.

BMAC is often used for more advanced joint degeneration or complex injuries where PRP alone may be insufficient. Precision imaging guidance using ultrasound or X-ray is essential for accurate aspiration and injection. Conditions addressed include moderate-to-severe osteoarthritis, cartilage defects, complex tendon and ligament injuries, and avascular necrosis. For a detailed comparison of these approaches, see our guide on BMAC vs stem cell therapy differences.

Exosome Therapy

Exosomes are extracellular vesicles: nanoscale particles released by cells that carry proteins, lipids, and genetic material. Exosomes derived from MSCs may deliver regenerative signals to damaged tissues without introducing live cells.

A critical regulatory caveat applies. In Q1 2026, the FDA issued warning letters to clinics in Florida, California, and Texas for marketing unapproved exosome products. Patients must verify that any provider offering exosome therapy operates within FDA-compliant protocols. Conditions addressed include joint degeneration, tendon injuries, and inflammatory conditions, though research remains ongoing.

Hyaluronic Acid Injections (Viscosupplementation)

Hyaluronic acid occurs naturally in joint fluid, providing lubrication and shock absorption. HA injections supplement depleted joint fluid in arthritic joints and represent one of the most established FDA-cleared injection therapies for knee osteoarthritis.

Treatment typically involves a series of injections over several weeks, with effects lasting several months. HA is often used alongside PRP or stem cell therapy in combination protocols. Conditions addressed include knee osteoarthritis and hip and shoulder joint degeneration.

Peptide Therapy

Peptides are short chains of amino acids that act as biological signaling molecules. Specific peptides such as BPC-157 and TB-500 are studied for potential roles in tissue repair, inflammation reduction, and recovery acceleration.

Peptide therapy represents one of the more emerging modalities in clinical regenerative medicine. Patients should ask about the evidence base and regulatory status for specific peptides offered. Delivery methods include subcutaneous injection or oral administration depending on the peptide. Conditions addressed include tendon and ligament repair, muscle recovery, and post-procedure recovery support.

The 2026 FDA Regulatory Landscape: What Texas Patients Must Understand

As of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions. This does not mean these treatments are illegal, but patients must understand the distinction between FDA-approved and FDA-compliant.

The FDA’s regulatory framework for regenerative therapies operates on two primary pathways. Biologics regulated under Section 351 require full Biologics License Application approval. Therapies meeting the “same surgical procedure” exception under Section 361, involving minimal manipulation and homologous use, operate under a different pathway.

In October 2025, the U.S. Supreme Court declined to reconsider a ruling confirming the FDA’s regulatory authority over unproven stem cell therapies, cementing federal oversight. In September 2025, the FDA released new draft guidance on expedited review pathways for regenerative medicine therapies for serious conditions. In December 2025, the FDA approved a gene-based stem cell therapy for Wiskott-Aldrich syndrome, demonstrating accelerating regulatory momentum.

Texas-specific legal context provides additional clarity. Texas Health and Safety Code Chapter 1003 permits adult stem cell use when properly manufactured, stored, and used within FDA-approved clinical trials. The Texas Medical Board requires that stem cell treatments either be part of an NIH or FDA-approved protocol or have IRB approval.

Five questions to ask any regenerative medicine provider:

1. Is this treatment part of an FDA-approved clinical trial or IRB-approved protocol?
2. What is the regulatory classification of the cells or products you use?
3. Can you provide documentation of your cell product’s manufacturing compliance?
4. What imaging guidance do you use for injections?
5. What outcomes data or clinical evidence supports your treatment approach?

Unicorn Bioscience operates within FDA regulatory frameworks and emphasizes U.S.-based treatment as an alternative to medical tourism, representing a meaningful trust signal for patients.

Texas’s Regenerative Medicine Research Ecosystem: Why the State Is a National Leader

Texas is not merely a market for regenerative treatments but a state at the forefront of research and innovation.

World-Class Research Institutions Driving Texas Innovation

UT Southwestern’s Hamon Center for Regenerative Science and Medicine in Dallas serves as an active research hub with faculty spanning cardiology, biomedical engineering, pharmacology, and ophthalmology. The Texas Heart Institute’s Regenerative Medicine Research Department in Houston, established in 2012, focuses on bio-artificial organs and understanding aging as a failure of stem cell function.

Texas A&M’s Institute for Regenerative Medicine, founded in 2008, conducts translational research in autoimmune disorders and age-related neurodegenerative diseases. UTSA’s Developmental and Regenerative Sciences PhD Program in San Antonio covers stem cell applications and biomaterials. UT Austin’s Institute for Biomaterials, Drug Delivery and Regenerative Medicine bridges materials science and regenerative biology.

Houston: The World’s Largest Medical Complex and a Global Regenerative Hub

The Texas Medical Center in Houston represents the largest medical complex in the world and a global hub for regenerative research. TMC Helix Park, a newly opened 37-acre innovation campus, is projected to create over 30,000 jobs and inject $5.2 billion annually into the regional economy by 2030. TMC launched Innovation Labs @ TMC in January 2026, a 34,000 square foot life science startup hub.

For patients in Houston, this institutional ecosystem means that clinical care at reputable private clinics exists within a city that takes regenerative medicine seriously at the highest levels of research and investment.

The 6-City Texas Access Guide: Regenerative Medicine Near You

Texas’s geographic scale of 268,000 square miles and over 30 million residents means that access to specialized care varies significantly by location. Unicorn Bioscience operates with a six-city Texas footprint, enabling statewide patient navigation. Virtual consultations are available as a first step for patients in any Texas city or rural area.

Houston: Regenerative Medicine in the World’s Medical Capital

Houston’s 2.3 million residents have access to the state’s most research-dense regenerative medicine environment. The diverse population includes significant Hispanic and African American communities with elevated rates of osteoarthritis and diabetes-related joint complications.

Unicorn Bioscience Houston: 12121 Richmond Ave., Suite #312, Houston, TX 77082

Conditions commonly treated include knee osteoarthritis, rotator cuff injuries, back pain, sports injuries, and plantar fasciitis. Same-day treatment availability serves Houston’s working population effectively.

Dallas: Regenerative Medicine in the Metroplex’s Innovation Corridor

The Dallas-Fort Worth metro area encompasses 7.5 million residents and hosts UT Southwestern’s Hamon Center. The large suburban population experiences high rates of sports-related injuries among active adults.

Unicorn Bioscience Dallas: 6200 Lyndon B Johnson Fwy, Suite 180, Dallas, TX 75240

Conditions commonly treated include knee and hip osteoarthritis, meniscus injuries, tendon injuries, and degenerative disc disease. Learn more about our stem cell therapy Dallas Texas clinic.

Fort Worth: Serving the Western Metroplex and Beyond

Fort Worth’s population of approximately 950,000 includes a large surrounding rural catchment area in North and West Texas. The significant ranching, agriculture, and blue-collar workforce experiences high rates of occupational joint injuries.

Unicorn Bioscience Fort Worth: 3712 W 7th St, Fort Worth, TX 76107

Fort Worth serves as a regional access point for patients from Abilene, Wichita Falls, Midland, and other West Texas communities. Virtual consultations allow patients to confirm candidacy before traveling. Patients across the region can also explore our regenerative medicine Dallas Fort Worth resource for additional guidance.

San Antonio: Serving Texas’s Military Community and South Texas Patients

San Antonio is home to Joint Base San Antonio, the largest military installation in the world by population. The large veteran and active-duty population experiences high rates of service-related orthopedic injuries. VA specialty care wait times average 28 days, creating significant demand for accessible alternatives.

Unicorn Bioscience San Antonio: 115 Gallery Cir, Suite 101, San Antonio, TX 78258

Conditions commonly treated include service-related joint injuries, knee and hip osteoarthritis, back pain, and shoulder injuries from physical training.

Austin: Regenerative Medicine for an Active, Health-Forward Population

Austin’s population exceeding one million includes a high concentration of athletes, cyclists, runners, and outdoor enthusiasts. The large tech-sector workforce tends to be highly informed and research-driven.

Unicorn Bioscience Austin: 2501 W William Cannon Dr, STE 208, Austin, TX 78745

Conditions commonly treated include sports injuries, plantar fasciitis, early-stage osteoarthritis, and tendon injuries. Patients preparing for a visit can review our stem cell therapy Austin readiness checklist before their appointment.

El Paso: Bridging the Border and Serving Far West Texas

El Paso’s approximately 700,000 residents include a large Hispanic population with elevated rates of osteoarthritis and diabetes-related joint complications. Fort Bliss represents one of the largest U.S. Army installations.

Unicorn Bioscience El Paso: 11240 Vista Del Sol, Suite C, El Paso, TX 79936

Patients who might otherwise consider crossing the border for lower-cost treatments can access cellular therapy in El Paso, Texas domestically, providing significant safety and regulatory advantages.

How to Evaluate Any Regenerative Medicine Provider in Texas: A Patient Checklist

The Texas regenerative medicine market includes providers of varying quality and regulatory compliance. Patients deserve tools to distinguish them.

Red Flags to Watch For

• Providers claiming FDA approval for stem cell, PRP, or exosome therapies for orthopedic conditions
• Clinics offering exosome products without clear documentation of regulatory compliance
• Providers who do not use imaging guidance for injections
• Websites or consultants guaranteeing outcomes or making cure claims
• Providers pressuring patients into immediate decisions or large upfront payments
• Clinics unable to explain the source and regulatory classification of their cell products

What a High-Quality Texas Regenerative Medicine Provider Looks Like

Quality indicators include board-certified medical professionals leading clinical care, transparent FDA regulatory status disclosure, imaging-guided injection protocols, personalized treatment planning, multi-modal treatment options, clear cost communication, virtual consultation availability, same-day treatment for qualified candidates, and documented outcomes tracking.

Unicorn Bioscience meets each of these criteria through board-certified physician leadership, FDA-compliant protocols, ultrasound-guided injection and X-ray guidance, personalized protocols, a six-modality treatment menu, transparent regulatory messaging, virtual consultations, and same-day treatment availability.

Understanding the Cost of Regenerative Medicine in Texas

Regenerative medicine treatments are almost universally classified as experimental by insurance providers. Approximately 95% of insurers do not cover these treatments, making them out-of-pocket expenses for most patients.

Transparent cost ranges include PRP at $500 to $2,000 per session and stem cell therapy at $3,000 to $7,500 per treatment. Complex multi-modal procedures can exceed $25,000. For context, total knee replacement surgery costs $30,000 to $50,000 or more, including facility, anesthesia, and rehabilitation. Patients weighing these options may find our regenerative medicine vs surgery outcomes comparison a useful resource.

Some patients may require multiple treatment sessions for optimal outcomes. Virtual consultations, often available at no cost or low cost, allow patients to understand full treatment costs before committing.

Conclusion: Navigating Regenerative Medicine in Texas

Regenerative medicine represents a legitimate and rapidly growing field with a strong evidence base for orthopedic conditions. Texas has both the research infrastructure and the clinical access to support patients across the state. While no stem cell, PRP, or exosome products are FDA-approved specifically for orthopedic conditions as of 2026, FDA-compliant providers operating within established frameworks offer safe, evidence-supported care.

Patients should evaluate providers by asking about regulatory status, imaging guidance, cell product sourcing, personalization, and outcomes data. Most treatments are out-of-pocket, but costs compare favorably to surgical alternatives when considering the full picture.

Whether located in Houston, Dallas, Fort Worth, San Antonio, Austin, El Paso, or a rural Texas community, regenerative medicine care is accessible through Unicorn Bioscience’s six Texas locations or via virtual consultation as a first step.

Ready to Explore Your Options? Start with a Consultation

Patients interested in learning more can schedule a virtual or in-person consultation at the Unicorn Bioscience location nearest to them:

• Houston: 12121 Richmond Ave., Suite #312, Houston, TX 77082
• Dallas: 6200 Lyndon B Johnson Fwy, Suite 180, Dallas, TX 75240
• Fort Worth: 3712 W 7th St, Fort Worth, TX 76107
• San Antonio: 115 Gallery Cir, Suite 101, San Antonio, TX 78258
• Austin: 2501 W William Cannon Dr, STE 208, Austin, TX 78745
• El Paso: 11240 Vista Del Sol, Suite C, El Paso, TX 79936

A consultation provides an opportunity for personalized clinical assessment, a review of treatment options, and the chance to ask questions without commitment to treatment. Same-day treatment is available for qualified candidates who prefer to move quickly.

Phone: (737) 347-0446
Website: unicornbioscience.com

The path to understanding available options starts with a single conversation.